porterhouse medical limited Company Information
Company Number
04547209
Next Accounts
Sep 2025
Shareholders
jon anthony hallows
brian nicholas parsons
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
4 windsor square, silver street, reading, berkshire, RG1 2TH
Website
www.porterhouse.bizporterhouse medical limited Estimated Valuation
Pomanda estimates the enterprise value of PORTERHOUSE MEDICAL LIMITED at £7.2m based on a Turnover of £7.2m and 1x industry multiple (adjusted for size and gross margin).
porterhouse medical limited Estimated Valuation
Pomanda estimates the enterprise value of PORTERHOUSE MEDICAL LIMITED at £7.8m based on an EBITDA of £1.1m and a 7.18x industry multiple (adjusted for size and gross margin).
porterhouse medical limited Estimated Valuation
Pomanda estimates the enterprise value of PORTERHOUSE MEDICAL LIMITED at £11m based on Net Assets of £4.8m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Porterhouse Medical Limited Overview
Porterhouse Medical Limited is a live company located in reading, RG1 2TH with a Companies House number of 04547209. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in September 2002, it's largest shareholder is jon anthony hallows with a 50% stake. Porterhouse Medical Limited is a mature, mid sized company, Pomanda has estimated its turnover at £7.2m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Porterhouse Medical Limited Health Check
Pomanda's financial health check has awarded Porterhouse Medical Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs


5 Strong

2 Regular

4 Weak

Size
annual sales of £7.2m, make it larger than the average company (£2.9m)
£7.2m - Porterhouse Medical Limited
£2.9m - Industry AVG

Growth
3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (7.2%)
- Porterhouse Medical Limited
7.2% - Industry AVG

Production
with a gross margin of 82.9%, this company has a lower cost of product (44.9%)
82.9% - Porterhouse Medical Limited
44.9% - Industry AVG

Profitability
an operating margin of 14.9% make it more profitable than the average company (5.7%)
14.9% - Porterhouse Medical Limited
5.7% - Industry AVG

Employees
with 58 employees, this is above the industry average (23)
58 - Porterhouse Medical Limited
23 - Industry AVG

Pay Structure
on an average salary of £53.9k, the company has an equivalent pay structure (£53.9k)
- Porterhouse Medical Limited
£53.9k - Industry AVG

Efficiency
resulting in sales per employee of £124.4k, this is equally as efficient (£125.8k)
£124.4k - Porterhouse Medical Limited
£125.8k - Industry AVG

Debtor Days
it gets paid by customers after 95 days, this is later than average (57 days)
95 days - Porterhouse Medical Limited
57 days - Industry AVG

Creditor Days
its suppliers are paid after 24 days, this is quicker than average (31 days)
24 days - Porterhouse Medical Limited
31 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Porterhouse Medical Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (24 weeks)
6 weeks - Porterhouse Medical Limited
24 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 65.5%, this is a higher level of debt than the average (53.3%)
65.5% - Porterhouse Medical Limited
53.3% - Industry AVG
PORTERHOUSE MEDICAL LIMITED financials

Porterhouse Medical Limited's latest turnover from December 2023 is £7.2 million and the company has net assets of £4.8 million. According to their latest financial statements, Porterhouse Medical Limited has 58 employees and maintains cash reserves of £1.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7,213,892 | ||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 1,231,367 | ||||||||||||||
Gross Profit | 5,982,525 | ||||||||||||||
Admin Expenses | 4,909,378 | ||||||||||||||
Operating Profit | 1,073,147 | ||||||||||||||
Interest Payable | 653 | ||||||||||||||
Interest Receivable | 339 | ||||||||||||||
Pre-Tax Profit | 1,072,833 | ||||||||||||||
Tax | 2,031 | ||||||||||||||
Profit After Tax | 1,074,864 | ||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | 1,074,864 | ||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 58 | 66 | 66 | 57 | 46 | 47 | 46 | 41 | |||||||
EBITDA* | 1,081,619 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 4,339 | 12,810 | 21,955 | 31,193 | 533,459 | 573,940 | 640,622 | 609,086 | 556,160 | 558,803 | 562,061 | 565,559 | 562,533 | 549,563 | 559,722 |
Intangible Assets | |||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 4,339 | 12,810 | 21,955 | 31,193 | 533,459 | 573,940 | 640,622 | 609,086 | 556,160 | 558,803 | 562,061 | 565,559 | 562,533 | 549,563 | 559,722 |
Stock & work in progress | |||||||||||||||
Trade Debtors | 1,881,715 | 1,559,455 | 2,002,798 | 887,710 | 900,229 | 464,215 | 1,011,629 | 759,292 | 1,104,605 | 705,550 | 618,841 | 645,911 | 269,217 | 360,741 | 371,818 |
Group Debtors | 10,214,158 | 7,866,267 | 4,271,391 | 860,360 | 777,580 | 467,380 | |||||||||
Misc Debtors | 558,707 | 521,664 | 797,273 | 737,369 | 2,349,082 | 2,050,788 | 1,698,591 | 1,033,878 | 216,829 | 144,444 | |||||
Cash | 1,190,343 | 587,729 | 1,106,055 | 803,896 | 692,033 | 934,574 | 1,518,858 | 1,336,898 | 420,357 | 357,684 | 446,792 | 162,501 | 247,994 | 269,149 | 510,065 |
misc current assets | |||||||||||||||
total current assets | 13,844,923 | 10,535,115 | 8,177,517 | 3,289,335 | 4,718,924 | 3,916,957 | 4,229,078 | 3,130,068 | 1,741,791 | 1,207,678 | 1,065,633 | 808,412 | 517,211 | 629,890 | 881,883 |
total assets | 13,849,262 | 10,547,925 | 8,199,472 | 3,320,528 | 5,252,383 | 4,490,897 | 4,869,700 | 3,739,154 | 2,297,951 | 1,766,481 | 1,627,694 | 1,373,971 | 1,079,744 | 1,179,453 | 1,441,605 |
Bank overdraft | 16,426 | 12,477 | 32,900 | ||||||||||||
Bank loan | 16,680 | ||||||||||||||
Trade Creditors | 84,151 | 43,185 | 58,907 | 33,222 | 84,366 | 79,965 | 86,000 | 120,931 | 794,951 | 621,624 | 578,836 | 611,641 | 480,128 | 575,143 | 812,830 |
Group/Directors Accounts | 6,891,226 | 5,477,197 | 3,993,736 | 567,369 | 740 | 740 | |||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 2,097,702 | 1,326,224 | 2,146,899 | 1,438,977 | 1,162,036 | 896,079 | 1,470,346 | 1,234,060 | |||||||
total current liabilities | 9,073,079 | 6,846,606 | 6,199,542 | 2,039,568 | 1,263,822 | 993,210 | 1,568,823 | 1,387,891 | 794,951 | 621,624 | 578,836 | 611,641 | 480,128 | 575,143 | 812,830 |
loans | 218,004 | 234,656 | 250,424 | 286,793 | 217,652 | 234,955 | 251,888 | 268,445 | 284,612 | 315,946 | |||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | 4,756 | 23,779 | 66,983 | 65,489 | 64,035 | 62,612 | 61,219 | 360,298 | 58,523 | ||||||
provisions | 5,374 | 23,935 | 30,488 | 40,613 | 37,961 | 16,688 | 17,319 | 17,646 | 17,109 | 13,100 | 12,066 | 11,959 | |||
total long term liabilities | 5,374 | 241,939 | 265,144 | 295,793 | 348,533 | 301,323 | 317,763 | 333,569 | 348,166 | 358,931 | 372,364 | 386,428 | |||
total liabilities | 9,073,079 | 6,846,606 | 6,199,542 | 2,044,942 | 1,505,761 | 1,258,354 | 1,864,616 | 1,736,424 | 1,096,274 | 939,387 | 912,405 | 959,807 | 839,059 | 947,507 | 1,199,258 |
net assets | 4,776,183 | 3,701,319 | 1,999,930 | 1,275,586 | 3,746,622 | 3,232,543 | 3,005,084 | 2,002,730 | 1,201,677 | 827,094 | 715,289 | 414,164 | 240,685 | 231,946 | 242,347 |
total shareholders funds | 4,776,183 | 3,701,319 | 1,999,930 | 1,275,586 | 3,746,622 | 3,232,543 | 3,005,084 | 2,002,730 | 1,201,677 | 827,094 | 715,289 | 414,164 | 240,685 | 231,946 | 242,347 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | Sep 2010 | Sep 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 1,073,147 | ||||||||||||||
Depreciation | 8,472 | 11,306 | 32,977 | 52,182 | 55,523 | 72,781 | 68,130 | 54,166 | 29,671 | 26,678 | 26,267 | 22,996 | 20,644 | 15,986 | 17,237 |
Amortisation | |||||||||||||||
Tax | 2,031 | ||||||||||||||
Stock | |||||||||||||||
Debtors | 2,707,194 | 2,875,924 | 4,586,023 | -1,541,452 | 1,044,508 | 272,163 | 917,050 | 471,736 | 471,440 | 231,153 | -27,070 | 376,694 | -91,524 | -11,077 | 371,818 |
Creditors | 40,966 | -15,722 | 25,685 | -51,144 | 4,401 | -6,035 | -34,931 | -674,020 | 173,327 | 42,788 | -32,805 | 131,513 | -95,015 | -237,687 | 812,830 |
Accruals and Deferred Income | 771,478 | -820,675 | 707,922 | 276,941 | 265,957 | -574,267 | 236,286 | 1,234,060 | |||||||
Deferred Taxes & Provisions | -5,374 | -18,561 | -6,553 | -10,125 | 2,652 | 21,273 | -631 | -327 | 537 | 4,009 | 1,034 | 107 | 11,959 | ||
Cash flow from operations | -811,100 | ||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | -16,680 | 16,680 | |||||||||||||
Group/Directors Accounts | 1,414,029 | 1,483,461 | 3,426,367 | 566,629 | 740 | ||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | -218,004 | -16,652 | -15,768 | -36,369 | 69,141 | -17,303 | -16,933 | -16,557 | -16,167 | 284,612 | -315,946 | 315,946 | |||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | -4,756 | -19,023 | -43,204 | 1,494 | 1,454 | 1,423 | 1,393 | -299,079 | 301,775 | 58,523 | |||||
share issue | |||||||||||||||
interest | -314 | ||||||||||||||
cash flow from financing | 1,413,715 | ||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 602,614 | -518,326 | 302,159 | 111,863 | -242,541 | -584,284 | 181,960 | 916,541 | 62,673 | -89,108 | 284,291 | -85,493 | -21,155 | -240,916 | 510,065 |
overdraft | -16,426 | 3,949 | -20,423 | 32,900 | |||||||||||
change in cash | 602,614 | -518,326 | 302,159 | 111,863 | -226,115 | -588,233 | 202,383 | 883,641 | 62,673 | -89,108 | 284,291 | -85,493 | -21,155 | -240,916 | 510,065 |
porterhouse medical limited Credit Report and Business Information
Porterhouse Medical Limited Competitor Analysis

Perform a competitor analysis for porterhouse medical limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in RG1 area or any other competitors across 12 key performance metrics.
porterhouse medical limited Ownership
PORTERHOUSE MEDICAL LIMITED group structure
Porterhouse Medical Limited has no subsidiary companies.
Ultimate parent company
STANDBYCO 17 BV
#0119251
2 parents
PORTERHOUSE MEDICAL LIMITED
04547209
porterhouse medical limited directors
Porterhouse Medical Limited currently has 4 directors. The longest serving directors include Mr Jon Hallows (Sep 2002) and Ms Alison Washer (Jul 2024).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jon Hallows | United Kingdom | 55 years | Sep 2002 | - | Director |
Ms Alison Washer | 55 years | Jul 2024 | - | Director | |
Mr Dan Spacie | United Kingdom | 53 years | Jul 2024 | - | Director |
Andrea Carrodus | 44 years | Jul 2024 | - | Director |
P&L
December 2023turnover
7.2m
0%
operating profit
1.1m
0%
gross margin
83%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
4.8m
+0.29%
total assets
13.8m
+0.31%
cash
1.2m
+1.03%
net assets
Total assets minus all liabilities
porterhouse medical limited company details
company number
04547209
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
September 2002
age
23
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
December 2023
previous names
N/A
accountant
INNOVI ADVISORS LTD
auditor
-
address
4 windsor square, silver street, reading, berkshire, RG1 2TH
Bank
-
Legal Advisor
-
porterhouse medical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to porterhouse medical limited. Currently there are 2 open charges and 2 have been satisfied in the past.
porterhouse medical limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PORTERHOUSE MEDICAL LIMITED. This can take several minutes, an email will notify you when this has completed.
porterhouse medical limited Companies House Filings - See Documents
date | description | view/download |
---|